Remidio
PrivateLast Round
Grant
Jun 10, 2026
Est. Valuation
$67.5M
Total Funding Raised
$22.08M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Remidio is a medical technology company that develops and manufactures AI-powered portable ophthalmic imaging devices designed to help diagnose eye diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remidio Comparables
Compare Remidio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Forus Health | 90% | |
| Phelcom Technologies | 87% | |
| Oivi | 83% | |
Remidio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 10, 2026 | ||||
| Corporate Funding | Feb 19, 2023 | ||||
| VC Round | Mar 31, 2022 | ||||
| Grant | Nov 18, 2020 | ||||
| VC Round | May 28, 2018 | ||||
Series B | Jan 15, 2016 |
Key People
Founding team and executive leadership
Remidio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IKP Knowledge Park | Seed |
| MedTech Innovator | Grant |
| Gates Foundation | Grant |
| Karnataka Information Technology Venture Fund | VC Round |
| Boundary Holding | VC Round |
| Cipher-Plexus Capital Advisors | Series B, Angel |
| Wellcome Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 66% MoM.
- Apr 1, 2026
Oculomics expands screening from eye to systemic diseases.
Remidio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Remidio's valuation, stock price, and market status.